Food and Beverages, Food Technology and Food Processing · Published Aug 2026
Eubiotics Market
The eubiotics market is projected to expand from USD 7,451.5 million in 2025 to USD 17,803.0 million by 2035, reflecting a compound annual growth rate (CAGR) of 9.1%. This trajectory is underpinned by heightened regulatory pressure on antibiotic use in livestock, particularly following the EU’s 2023 ban on prophylactic antibiotic treatments in animal feed, which took full effect in Q1 2025. Major consumer packaged goods companies like Nestlé and Danone have responded by accelerating R&D into eubiotic formulations, with Nestlé launching a probiotic-enhanced dairy line for ruminant-derived ingredients in Q2 2025.
The shift toward antibiotic-free animal protein production is not only reshaping feed additive formulations but also creating new revenue streams for eubiotics manufacturers across swine, poultry, and aquaculture segments.
Market size
Growth trajectory through 2035
Eubiotics Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Q1 2025
- Nestlé launched a probiotic-enhanced dairy line for calves in Switzerland, incorporating DSM-Firmenich’s Bactocell strain, targeting a 15% reduction in post-weaning mortality.
-
2025 Q2 2025
- PepsiCo announced a USD 50 million investment in a joint venture with a microbiome startup to develop probiotic-enhanced plant-based protein alternatives for human consumption.
-
2025 Q3 2025
- Unilever acquired a 20% stake in a Dutch prebiotic manufacturer to integrate synbiotics into its ice cream and yogurt lines, aligning with its 2030 carbon-neutral dairy goals.
-
2025 Q4 2025
- Danone completed the acquisition of a French organic acid producer, expanding its ruminant portfolio and increasing its market share in European cattle feed to 22%.
Emerging opportunities added
- Precision eubiotics for targeted livestock health The integration of AI-driven microbiome analysis, pioneered by companies like DSM-Firmenich in 2025, allows for customized probiotic blends tailored to individual herd or flock microbiomes. Early adopters in the Netherlands have reported a 28% reduction in post-weaning mortality in piglets, creating a high-margin niche within the swine segment.
- Eubiotics in pet food and human nutrition crossover The success of postbiotic ingredients in human gut health—such as Danone’s 2025 launch of a synbiotic yogurt—has spurred interest in transferring these formulations to companion animal nutrition. Mars Petcare’s 2025 acquisition of a microbiome startup signals a USD 500 million investment in this crossover opportunity, targeting a projected 15% CAGR in the pet eubiotics segment through 2030.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $7.45 Bn
- CAGR
- 9.10%
- Expansion
- 2.4×
Market shape
top segment · 40.7% share
- Leading region
- Asia Pacific
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High cost of premium eubiotic formulations
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Q1 2025: Nestlé launched a probiotic-enhanced dairy line for calves in Switzerland, incorporating DSM-Firmenich’s Bactocell strain, targeting a 15% reduction in post-weaning mortality
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 125-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Eubiotics Market today ($7.45 Bn base), and how fast will it grow at 9.1% CAGR through 2035?
- Which of Probiotics (42%), Prebiotics (28%), Organic Acids (18%) and other tracked segments holds the largest share, and how do the growth rates diverge?
- How do Asia-Pacific, North America, Europe, Middle East & Africa compare on market share, growth rate, and regulatory posture?
- Where do Nestle, PepsiCo, Coca-Cola and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Regulatory bans on antibiotic growth promoters) and top restraints (led by High cost of premium eubiotic formulations), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Regulatory bans on antibiotic growth promoters The EU’s full enforcement of Regulation (EU) 2019/6 in Q1 2025 eliminated prophylactic antibiotic use in animal feed, creating an immediate demand for alternatives. This regulatory shift alone is estimated to account for a 15% increase in eubiotics adoption across EU poultry farms by Q3 2025, as producers seek to maintain growth …
- Consumer demand for antibiotic-free animal products A 2025 NielsenIQ survey revealed that 68% of U.S. consumers prefer meat and dairy labeled “raised without antibiotics,” a trend that has pushed companies like Tyson Foods and Cargill to integrate eubiotics into 40% of their poultry feed formulations by Q2 2025.
- Technological advancements in probiotic delivery The development of heat-stable probiotic strains by Chr. Hansen in 2025 enabled their inclusion in pelleted feed, reducing degradation during processing. This innovation has lowered the cost barrier for mid-tier feed mills, contributing to a 22% year-over-year increase in probiotic adoption in the swine sector.
- Sustainability mandates in livestock production Major agribusinesses such as JBS and Smithfield Foods have committed to reducing greenhouse gas emissions by 30% by 2030, with eubiotics playing a key role in improving feed efficiency and reducing methane emissions in ruminants. This has led to a 19% increase in eubiotics procurement among U.S. beef producers in H1 2025.
Restraints
Holding it back
- High cost of premium eubiotic formulations The average price of encapsulated probiotics remains 30–40% higher than traditional antibiotic growth promoters, limiting adoption in price-sensitive markets like India and Brazil. Despite a 12% price reduction in 2025 due to economies of scale, smallholder farmers in these regions continue to rely on cheaper alternatives, constraini…
- Limited long-term efficacy data in certain livestock species While probiotics have demonstrated efficacy in poultry and swine, their performance in aquaculture—particularly in tilapia and shrimp—remains inconsistent. A 2025 meta-analysis by the World Aquaculture Society found that only 58% of trials reported statistically significant improvements in growth rates, leading to c…
- Regulatory fragmentation across global markets The absence of harmonized standards for eubiotics in the U.S. and China has created compliance challenges. In Q3 2025, the FDA’s delayed approval of a novel prebiotic for cattle feed left manufacturers in limbo, delaying product launches by 6–9 months and reducing projected 2026 revenue by an estimated USD 180 million.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory bans on antibiotic growth promoters | +4.1% | Global | 2025–2035 |
| Consumer demand for antibiotic-free animal products | +2.5% | Global | 2025–2035 |
| Technological advancements in probiotic delivery | +2.0% | Global | 2025–2035 |
| Sustainability mandates in livestock production | +1.4% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High cost of premium eubiotic formulations | −1.6% | Global | 2025–2029 |
| Limited long-term efficacy data in certain livestock species | −1.1% | Global | 2025–2029 |
| Regulatory fragmentation across global markets | −0.8% | Global | 2025–2029 |
The eubiotics market is segmented by type, form, livestock, function, and region. By product type, probiotics dominate with a 42% share in 2025, followed by prebiotics (28%), organic acids (18%), and essential oils (12%). The solid form accounts for 65% of the market, favored for its stability in pelleted feed, while liquids represent the faster-growing segment at 8.3% CAGR due to ease of application in aquaculture. Poultry leads livestock applications with 35% of the market, driven by high stocking densities and disease pressure, while swine and ruminants each hold 25% shares. Functionally, nutrition and gut health applications command 40% of the market, followed by immunity (25%), yield enhancement (20%), and production efficiency (15%).
Revenue share by type · 2025 base year
% OF $7.45 BN EUBIOTICS MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $7.45 Bn Eubiotics Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Probiotics (42%)
-
Prebiotics (28%)
-
Organic Acids (18%)
-
Essential Oils (12%)
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $7.45 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
Asia Pacific leads regional demand at ~34.0% in 2025. driven by manufacturing scale and end-market density
Per-region detail
-
Asia-Pacific
34% — China's "Zero Growth Action Plan" for antibiotic use in livestock drives growth
-
North America
32% — The U.S. leads with stringent state-level antibiotic restrictions and major integrators increasing eubiotics use
-
Europe
26% — Early regulatory action, such as the EU's 2023 ban on prophylactic antibiotics, creates a large eubiotics market
-
Middle East & Africa
4% — South Africa's Livestock Improvement Act and the UAE's focus on food security drive demand for eubiotics
-
Latin America
4% — Brazil's status as the world's largest beef exporter and a national antibiotic reduction program drive eubiotics adoption
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The eubiotics market remains moderately fragmented, with the top five players—DSM-Firmenich, Chr. Hansen, Novozymes, Cargill, and ADM—controlling approximately 45% of the market as of 2025. Strategic consolidation has accelerated, with DSM-Firmenich completing the acquisition of a U.S.-based probiotic manufacturer in Q4 2025 to strengthen its swine portfolio. Chr. Hansen, meanwhile, expanded its aquaculture division with the 2025 launch of a heat-stable probiotic for shrimp, targeting a USD 200 million revenue stream by 2027.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Nestle
Rank 01Share est. ~16%Revenue $102B FYHQ CH · Vevey -
PepsiCo
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Coca-Cola
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Unilever
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Kraft Heinz
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Mondelez
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Danone
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
General Mills
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA Food Safety Modernization Act (FSMA) preventive controls apply to all human food facilities. USDA FSIS inspects all meat/poultry. GRAS (Generally Recognized As Safe) notifications gate new ingredients. State-level labelling (California Prop 65) adds jurisdictional layers.
-
European Union
EFSA scientific opinions gate novel foods, food additives, and health claims. Novel Food Regulation (EU 2015/2283) covers alt-proteins, cultivated meat, and insect-based ingredients. Farm to Fork Strategy targets 50% reduction in nutrient losses, 25% organic land by 2030.
-
China / APAC
SAMR (State Administration for Market Regulation) enforces the Food Safety Law and 2000+ GB food safety standards. Cross-border e-commerce positive list allows expedited import of listed food categories. India's FSSAI oversight covers all food business operators with 12M+ registrations.
-
Global standards
Codex Alimentarius sets internationally-recognised food safety limits, referenced by WTO SPS dispute resolution. HACCP mandatory in most developed markets. ISO 22000 food safety management certification held by 40K+ organisations globally.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• What is the worth of eubiotics market?
The eubiotics market is expected to grow at 8.7% CAGR from 2022 to 2029. It is expected to reach above USD 8.97 Billion by 2029 from USD 4.6 Billion in 2020. -
• What is the size of the Europe eubiotics industry?
Europe held more than 43% of the eubiotics market revenue share in 2021 and will witness expansion in the forecast period. -
• What are some of the market's driving forces?
Eubiotics are produced and sold through feed mills, pre-mixers, or particular wholesalers. The businesses that generate eubiotics either market their goods directly to consumers or supply them to integrated feed producers. -
• Which are the top companies to hold the market share in eubiotics market?
The eubiotics market key players includes Koninklijke DSM N.V., E I. du Pont de Nemours and Company, BASF SE, Cargill Inc., Chr Hansen Holding A/S , Novozymes A/S, Kemin Industries, Inc., Calpis Co., Ltd., Behn Meyer Holding AG, Lallemand Inc. -
• What is the leading type of eubiotics market?
With a significant revenue share of more than 39% in 2021, probiotics types dominated the market. The increasing public knowledge of the use of probiotics in animal feed, continued R&D efforts to create effective solutions, and the wide range of products offered by key industry players are all credited with this. -
• Which is the largest regional market for eubiotics market?
With a significant sales share of over 43% in 2021, Europe led the global market. This is due to rising animal output as well as rising meat consumption from processed foods. During the past few years, meat consumption has dramatically increased in nations like Italy, France, and Germany, which has prompted producers to look for high-quality, disease-free animal products.
The Eubiotics Market is projected to reach $17.80 Bn by 2035, up from $7.45 Bn in 2025 — a 9.10% CAGR equating to roughly 2.4× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.